Personal Protective Equipment (PPE) decontamination for reuse
The Battelle CCDS Critical Care Decontamination System™ addresses the current shortage of critical Personal Protective Equipment (PPE) across the United States. Battelle CCDS™ is designed to work on N95 respirators for the removal of the novel coronavirus (SARS-CoV-2).
Battelle CCDS™ can decontaminate thousands of N95 respirators using concentrated, vapor phase hydrogen peroxide. The respirators are exposed at the validated concentration level to decontaminate biological contaminants, including the SARS-CoV-2. Battelle CCDS™ can decontaminate the same respirator multiple times without degrading N95 respirator performance.
Battelle CCDS™ draws on decades of research and is grounded on an FDA study Battelle completed following a 2016 contagion. NIOSH has tested and verified the CCDS methodology through 20 decontamination cycles per respirator. Battelle is currently conducting research to validate that other equipment, including surgical masks and ventilator components, can be decontaminated using this process.
Healthcare systems will collect worn N95 respirators each day in accordance with an approved procedure, and the PPE will be labeled with a barcoded serial number for tracking the chain-of-custody throughout the decontamination process. This procedure ensures that the hospital system receives its own respirators back.
Check out the documents below for information on how your healthcare system or personnel can use the Battelle CCDS Critical Care Decontamination System™
Click on the image of the document to the left for information about the preparation and collection of compatible N95 respirators for decontamination by Battelle using the Battelle CCDS Critical Care Decontamination System™.
Click on the image of the document to the left for information about the preparation of compatible N95 respirators for decontamination by Battelle using the Battelle CCDS Critical Care Decontamination System™
Click on the image of the document to the left to review this fact sheet. The fact sheet informs you of the significant known and potential risks and benefits of the emergency use of decontaminated N95 or N95-equivalent respirators. These respirators have been decontaminated using the Battelle CCDS Critical Care Decontamination System™
Click on the image of the document to the left to review the U.S. Food and Drug Administration's Emergency Use Authorization (EUA) for the use of the Battelle CCDS Critical Care Decontamination System™ in decontaminating compatible N95 or N95-equivalent respirators for reuse by healthcare personnel to prevent exposure to pathogenic biological airborne during the COVID-19 pandemic.
Battelle, with years of expertise in infectious diseases, developed a game-changing mask sanitation technology for healthcare systems across the c...Learn More about COVID-19: Hearing from the Front Lines on Impact of Battelle CCDS
Battelle is working with commercial, academic and government entities to support the global efforts to understand, test and treat the virus.Learn More about COVID-19: Propelling the Unknown into the Known
Pharma companies are realizing that for many products, success no longer solely depends on the medication itself delivering therapeutic success.Learn More about Driving Forces, Challenges & Delivery Methods for Biologics
Battelle designed and built the CCDS Critical Care Decontamination System™ for decontaminating single-use disposable N95 PPE, allowing for reuse.Learn More about COVID-19: Deploying a Critical New PPE Decontamination System